Cargando…

Real-world evidence for option value in metastatic melanoma

BACKGROUND: The concept of real option value (ROV) suggests there is added value in treatments that extend life because they enable a patient to live long enough to benefit from future innovative treatments. Real-world evidence of this novel value element is scant, limiting its consideration in form...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, William B, To, Tu My, Li, Meng, Lee, Woojung, Veenstra, David L, Garrison, Louis P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394183/ https://www.ncbi.nlm.nih.gov/pubmed/34431715 http://dx.doi.org/10.18553/jmcp.2021.21192

Ejemplares similares

Modeling the Ex Ante Clinical Real Option Value in an Innovative Therapeutic Area: ALK-Positive Non-Small-Cell Lung Cancer
por: Lee, Woojung, et al.
Publicado: (2022)

The use of real-world evidence in ICER’s scoping process and clinical evidence assessments
por: Jiao, Boshen, et al.
Publicado: (2020)

Use of real-world evidence in economic assessments of pharmaceuticals in the United States
por: Lee, Woojung, et al.
Publicado: (2021)

Real world evidence of Lenvatinib + anti PD-1 as an advanced line for metastatic melanoma
por: Stoff, Ronen, et al.
Publicado: (2023)

A real world example of coverage with evidence development in Australia - ipilimumab for the treatment of metastatic melanoma
por: Kim, Hansoo, et al.
Publicado: (2018)

Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma
por: Asher, Nethanel, et al.
Publicado: (2020)

Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
por: Bol, Kalijn Fredrike, et al.
Publicado: (2019)

Using Certification to Promote Uptake of Real-World Evidence by Payers
por: Segal, Jodi B., et al.
Publicado: (2016)

Informing real-world practice with real-world evidence: the value of PRECIS-2
por: Neta, Gila, et al.
Publicado: (2018)

Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma
por: Kartolo, Adi, et al.
Publicado: (2022)

The value of real world evidence: The case of medical cannabis
por: Schlag, Anne Katrin, et al.
Publicado: (2022)

Understanding the Economic Value of Molecular Diagnostic Tests: Case Studies and Lessons Learned
por: Towse, Adrian, et al.
Publicado: (2013)

Abscopal Response in Metastatic Melanoma: Real-World Data of a Retrospective, Multicenter Study
por: Ollivier, Luc, et al.
Publicado: (2022)

Real-world analyses of therapy discontinuation of checkpoint inhibitors in metastatic melanoma patients
por: Machado, Marina Amaral de Ávila, et al.
Publicado: (2020)

Third-line treatment options in metastatic pancreatic cancer patients: a real-world study
por: Lu, Hong-Rui, et al.
Publicado: (2023)

The intelligent option investor: applying value investing to the world of options
por: Kobayashi-Solomon, Erik
Publicado: (2015)

Treatment patterns and clinical outcomes for patients with melanoma and central nervous system metastases: A real‐world study
por: Tawbi, Hussein, et al.
Publicado: (2021)

Treatment options for metastatic melanoma in solid organ transplant recipients
por: Shin, Thuzar M., et al.
Publicado: (2015)

A novel combinatorial treatment option for metastatic uveal melanoma
por: Shneor, Dudi, et al.
Publicado: (2018)

Metastatic disease from uveal melanoma: treatment options and future prospects
por: Carvajal, Richard D, et al.
Publicado: (2017)

Editorial on Special Issue “Advances and Novel Treatment Options in Metastatic Melanoma”
por: Carè, Alessandra, et al.
Publicado: (2022)

STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world
por: Shire, Norah J., et al.
Publicado: (2020)

Retrospective Analysis of Treatment-naive Slovenian Patients with Metastatic Melanoma Treated with Pembrolizumab – Real-world Experience
por: Hribernik, Nezka, et al.
Publicado: (2020)

Real-world experience with elective discontinuation of PD-1 inhibitors at 1 year in patients with metastatic melanoma
por: Pokorny, Rebecca, et al.
Publicado: (2021)

Impact of staging on survival outcomes: a nationwide real-world cohort study of metastatic uveal melanoma
por: Rantala, Elina S., et al.
Publicado: (2021)

Understanding Real-World Treatment Patterns and Clinical Outcomes among Metastatic Melanoma Patients in Alberta, Canada
por: O’Sullivan, Dylan E., et al.
Publicado: (2023)

Anti‐PD‐1 antibodies in metastatic uveal melanoma: a treatment option?
por: Bender, Carolin, et al.
Publicado: (2017)

RAC1 Activation as a Potential Therapeutic Option in Metastatic Cutaneous Melanoma
por: Colón-Bolea, Paula, et al.
Publicado: (2021)

Real Check RIO: A Real-World Analysis of Nivolumab in First Line Metastatic Melanoma Assessing Efficacy, Safety and Predictive Factors
por: Afrăsânie, Vlad-Adrian, et al.
Publicado: (2023)

Real‐World Evidence in EU Medicines Regulation: Enabling Use and Establishing Value
por: Arlett, Peter, et al.
Publicado: (2021)

Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making
por: Chen, Shuxian, et al.
Publicado: (2021)

Real-world Evidence of the Herb-drug Interactions
por: Pan, Hsueh-Yi, et al.
Publicado: (2022)

Real-World Evidence for Equality
por: Johnson, C. Erwin, et al.
Publicado: (2021)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

Comparative Effectiveness of Palliative Chemotherapy in Metastatic Breast Cancer: A Real‐World Evidence Analysis
por: Feinberg, Bruce, et al.
Publicado: (2020)

Real-world treatment practice in patients with advanced melanoma
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2020)

Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
por: Chan, Kelvin, et al.
Publicado: (2020)

The Increasing Importance of Rigorous Real-World Evidence
por: Yang, David D, et al.
Publicado: (2022)

Dabrafenib in metastatic melanoma: a monocentric ‘real life’ experience
por: Cocorocchio, E, et al.
Publicado: (2016)

Proceed with Caution When Using Real World Data and Real World Evidence
por: Kim, Hun-Sung, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jf435fe79q463r543ri6on05mi